111 related articles for article (PubMed ID: 17241428)
1. Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells.
Ho YC; Tai KW; Chang YC
Oral Dis; 2007 Jan; 13(1):40-4. PubMed ID: 17241428
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in KB cells by pingyangmycin.
Tai KW; Chou MY; Hu CC; Yang JJ; Chang YC
Oral Oncol; 2000 Mar; 36(2):242-7. PubMed ID: 10745179
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effect of pingyangmycin on cultured KB cells.
Tai KW; Chang YC; Chou LS; Chou MY
Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
[TBL] [Abstract][Full Text] [Related]
4. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Gong JH; Liu XJ; Li Y; Zhen YS
Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
[TBL] [Abstract][Full Text] [Related]
6. [Effect of antibody-targeted chemotherapy with pingyangmycin on prostate cancer cells in vitro].
Chen WZ; Zhang Y; Liang CS; Xie Y; Wen QQ; Gao X
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):406-8. PubMed ID: 18359702
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Dai Y; Liu XJ; Zhen YS
Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy with higher or lower dose of teniposide combined with cisplatin and pingyangmycin for oral squamous cell carcinoma].
Chen WT; Guo W; Xu Q; Pan HY; Ye DX; Qiu WL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):218-20. PubMed ID: 15196390
[TBL] [Abstract][Full Text] [Related]
9. [Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells].
Kong WD; Li YH; Zeng QL; Chen Y; He XF
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):830-2, 836. PubMed ID: 12919911
[TBL] [Abstract][Full Text] [Related]
10. Relationship between intracellular glutathione level and the mode of cell death induced by pingyangmycin.
Tai KW; Lii CK; Chou MY; Chang YC
Oral Oncol; 2003 Jan; 39(1):13-8. PubMed ID: 12457716
[TBL] [Abstract][Full Text] [Related]
11. [Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
Sun ML; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Jun; 28(3):257-60. PubMed ID: 20635652
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of pingyangmycin-induced apoptosis of cultured human umbilical vein endothelial cells.
Huang YD; Tong X; Chen Q; Xia SW; Zhuo Y; Kang ZH; Xue XY
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28510249
[TBL] [Abstract][Full Text] [Related]
13. [The role of mitogen-activated protein kinase (MAPK) pathway in the action mechanism of PYM-induced KB cells apoptosis].
Dai G; Zhang Z; Zhou M; Yu S
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):97-8. PubMed ID: 12475417
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of interstitial chemotherapy with PYM delivered from a solid implantable biodegradable polymer against human tongue SCC in tumor-bearing nude mice].
Chen CJ; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):519-24. PubMed ID: 16288335
[TBL] [Abstract][Full Text] [Related]
15. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells.
Zheng G; Zhou M; Ou X; Peng B; Yu Y; Kong F; Ouyang Y; He Z
FEBS J; 2010 Nov; 277(21):4506-18. PubMed ID: 21040473
[TBL] [Abstract][Full Text] [Related]
16. [The effect of ginkgolic acids on multidrug resistance in oral squamous cell carcinoma].
Wang H; Zhou CC; Feng Y; Dai LN; Chen J; Chen SX; Li XY; Liu YR; Zhang P
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Dec; 28(6):668-71. PubMed ID: 21365850
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein.
Li B; Zheng YB; Li DD; Zhen YS
J Pharm Sci; 2014 Apr; 103(4):1204-13. PubMed ID: 24504597
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Treatment of Large Venous Malformations in the Oral and Maxillofacial Regions Using Electrochemical Therapy Combined With Pingyangmycin.
Xue L; Cao RY; Xu DP; Sun NN; Tan HS; Wang XK
J Oral Maxillofac Surg; 2015 Jul; 73(7):1384-91. PubMed ID: 25913514
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates.
Liu X; Zhen Y
Chin Med Sci J; 2002 Mar; 17(1):1-6. PubMed ID: 12894876
[TBL] [Abstract][Full Text] [Related]
20. Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity.
Okamura H; Morimoto H; Haneji T
Oral Oncol; 2001 Jun; 37(4):379-85. PubMed ID: 11337271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
